Close
Help




JOURNAL

Clinical Medicine Reviews in Therapeutics

Current and Emerging Pharmacotherapies in Children with Moderate to Severe Chronic Asthma

Submit a Paper


Clinical Medicine Reviews in Therapeutics 2011:3

Review

Published on 15 Jun 2011

DOI: 10.4137/CMRT.S3307


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Reviews in Therapeutics

Abstract

Moderate to severe chronic asthma in children provides challenges in both diagnosis and treatment for paediatricians. The clinician treating difficult to control asthma meets a number of challenges such as non-adherence and paucity of strong clinical evidence. Understanding different asthma phenotypes, pathophysiology and the inflammatory process that underpins asthma is essential in order to appreciate the action of the pharmacotherapies available for use beyond the British Thoracic Society Guidelines. Many of the newer drugs used today are inspired by other inflammatory diseases. Through this review we have summarised these issues for the reader and outlined the emerging therapies that may be available in the future.



Downloads

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)


Sharing


What Your Colleagues Say About Libertas Academica
I was delighted to submit an invited review on cluster headache pharmacology.  As someone who writes a few papers per year on these subjects, I appreciated that the submission, review and approval process for the paper was smooth and efficient. Our reviewers raised important points that improved the overall quality of the manuscript. Overall a very positive experience.
Dr Michael J. Marmura (Thomas Jefferson University, Philadelphia, PA, USA)
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube